Whole-genome and multisector exome sequencing of primary and post-treatment glioblastoma reveals patterns of tumor evolution

Whole-genome and multisector exome sequencing of primary and post-treatment glioblastoma reveals patterns of tumor evolution

Glioblastoma (GBM) is a prototypical heterogeneous brain tumor refractory to conventional therapy. A small residual population of cells escapes surgery and chemoradiation, resulting in a typically fatal tumor recurrence ~7 mo after diagnosis. Understanding the molecular architecture of this residual...

Full description

Bibliographic Details
Main Authors: Kim, Hoon (Author), Zheng, Siyuan (Author), Amini, Seyed S. (Author), Virk, Selene M. (Author), Mikkelsen, Tom (Author), Brat, Daniel J. (Author), Grimsby, Jonna (Author), Sougnez, Carrie (Author), Muller, Florian (Author), Hu, Jian (Author), Sloan, Andrew E. (Author), Cohen, Mark L. (Author), Van Meir, Erwin G. (Author), Scarpace, Lisa (Author), Laird, Peter W. (Author), Weinstein, John N. (Author), Gabriel, Stacey B. (Author), Getz, Gad (Author), Meyerson, Matthew L. (Author), Chin, Lynda (Author), Barnholtz-Sloan, Jill S. (Author), Verhaak, Roel G.W (Author), Lander, Eric Steven (Author)
Other Authors: Massachusetts Institute of Technology. Department of Biology (Contributor), Lander, Eric S. (Contributor)
Format: Article
Language:English
Published: Cold Spring Harbor Laboratory Press, 2015-08-04T19:20:24Z.
Subjects:
Article
Online Access:Get fulltext

Internet

Get fulltext

Similar Items